Human medicines European public assessment report (EPAR): Amgevita, adalimumab, Date of authorisation: 21/03/2017, Revision: 15, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 23 April 2026 - 12:00

Human medicines European public assessment report (EPAR): Amgevita, adalimumab, Date of authorisation: 21/03/2017, Revision: 15, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/amgevita

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters